Adequate antihypertensive therapy in the elderly will significantly reduce cardiovascular morbidity and mortality. The blood pressure goal in the very elderly is 150/80 mmHg. More effort is ...

Purpose. Intravenous antihypertensive agents for the treatment of hypertensive emergencies are reviewed. Summary. An estimated 500,000 people in the United States experience a hypertensive crisis ...

Frailty nurse specialist Linda Nazarko advises on what nurses in general practice need to be aware of when reviewing and ...

Jon Congleton; Chief Executive Officer, Director; Mineralys Therapeutics Inc. David Rodman; Chief Medical Officer ...

Anticipate topline data from pivotal Advance-HTN trial in March 2025 and pivotal Phase 3 Launch-HTN trial in mid first half of 2025 – – Completed enrollment in Explore-CKD Phase 2 trial and anticipate ...

Vitamin D3 supplementation was associated with antihypertensive effects without significant between-dose differences among overweight older adults.

Reduced baroreflex sensitivity is tied to an increased risk for dementia in older adults who do not take antihypertensive medications.

CEO Jon Congleton highlighted the company's focus on advancing its pivotal trials for lorundrostat, targeting dysregulated aldosterone in patients with uncontrolled and resistant hypertension. He ...

Q4 2024 Earnings Call Transcript February 12, 2025 Mineralys Therapeutics, Inc. beats earnings expectations. Reported EPS is ...

Today, millions of Americans live with undetected hypertension, unaware that it can impact even the healthiest of individuals — a lesson that Naomi Saucer* would come to learn ...

Background Cardiovascular disease (CVD) remains a significant public health challenge in China. This study aimed to project ...

Primary aldosteronism treatment response was associated with higher plasma renin activity and serum potassium levels and lower aldosterone.